FY2027 EPS Forecast for Spectral AI Lowered by Analyst

Spectral AI, Inc. (NASDAQ:MDAI – Free Report) – Research analysts at Northland Securities dropped their FY2027 earnings estimates for shares of Spectral AI in a report issued on Wednesday, November 11th. Northland Securities analyst L. Horton now anticipates that the company will post earnings per share of ($0.35) for the year, down from their prior forecast of ($0.34). Northland Securities currently has a “Strong-Buy” rating on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.50) per share.

A number of other research firms also recently commented on MDAI. Weiss Ratings upgraded Spectral AI from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, October 28th. Wall Street Zen raised Spectral AI from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $4.00.

Get Our Latest Stock Analysis on Spectral AI

Spectral AI Trading Down 3.7%

Spectral AI stock traded down $0.05 during mid-day trading on Friday, hitting $1.30. The company’s stock had a trading volume of 136,949 shares, compared to its average volume of 139,976. The firm has a market capitalization of $41.85 million, a PE ratio of -3.94 and a beta of 1.25. Spectral AI has a 1 year low of $1.18 and a 1 year high of $2.97. The stock’s fifty day moving average is $1.56 and its two-hundred day moving average is $1.69.

Spectral AI (NASDAQ:MDAI – Get Free Report) last released its quarterly earnings results on Tuesday, November 10th. The company reported ($0.14) EPS for the quarter, meeting the consensus estimate of ($0.14). The firm had revenue of $2.86 million for the quarter, compared to analysts’ expectations of $5.33 million.

Institutional Investors Weigh In On Spectral AI

A number of institutional investors have recently made changes to their positions in the stock. Rathbones Group PLC acquired a new position in shares of Spectral AI in the 3rd quarter worth approximately $144,000. State Street Corp increased its holdings in Spectral AI by 17.1% in the 3rd quarter. State Street Corp now owns 88,500 shares of the company’s stock valued at $147,000 after purchasing an additional 12,900 shares during the last quarter. Finally, Marshall Wace LLP acquired a new stake in Spectral AI in the 3rd quarter valued at approximately $1,073,000. 67.08% of the stock is currently owned by institutional investors and hedge funds.

Spectral AI Company Profile

(Get Free Report)

Spectral AI, Inc. develops medical diagnostic technology that combines artificial intelligence with multispectral imaging to help clinicians assess wounds. Its work focuses on providing information about wound severity and healing potential. The company’s lead product, the DeepView System, is being developed for burn wounds and diabetic foot ulcers. It is designed to analyze images of a wound and support clinicians in evaluating tissue viability and likely healing outcomes. Based in Dallas, Texas, Spectral AI was formerly known as Spectral MD Holdings and began trading publicly in 2023 after completing a business combination.

Featured Articles

Earnings History and Estimates for Spectral AI (NASDAQ:MDAI)

Receive News & Ratings for Spectral AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral AI and related companies with MarketBeat.com's FREE daily email newsletter.